Here are five things to know:
1. Acantha filed a patent for orthopedic technology used to join bone segments, U.S. Patent No. RE43,008(‘008), in 2001 and the patent was reissued in 2011.
2. The co-inventors of the technology, David Talaber and James Lloyd, MD, connected with DePuy Synthes about the patent in the mid-2000s; Dr. Lloyd even traveled to DePuy Synthes’ headquarters in 2005 to explain the technology and how it could help the company with problems it was experiencing.
3. DePuy did not license the patent for the technology; however Acantha alleged DePuy used the technology in a series of spinal implants, including its Zero-P VA System and Vectra.
4. Acantha sued DePuy Synthes over the patent dispute, and a jury in Green Bay, Wis., found DePuy did willfully infringe on Acantha’s patent.
5. The jury awarded Acantha $8.2 million in actual damages.
More articles on orthopedic devices:
K2M generates $73.6M in Q2 revenue: 5 financial reports
These 3 companies dominate the global hip & knee surgical implants market
Top 10 device companies in the spine surgery product market
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
